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Abstract
Background: Left ventricular (LV) rotation, twist, and torsion are important aspects of the 
cardiac performance. Myocardial fibrosis can be identified as the late gadolinium enhancement 
(LGE) in cardiac magnetic resonance (CMR). In this study, we investigated the association 
between myocardial fibrosis and LV rotational parameters in patients with nonischemic dilated 
cardiomyopathy (NDC).
Methods: Twenty-two NDC patients were enrolled. LV dimensions, volumes and ejection 
fraction (EF) were measured, conventional tissue Doppler imaging data was acquired. Speckle 
tracking imaging was performed to measure LV deformation, LV rotational parameters. Blood 
samples were obtained for NT-proBNP. Late gadolinium enhanced cardiac magnetic resonance 
(LGE-CMR) was used to assess cardiac fibrosis index. 
Results: Myocardial deformation was similar between LGE+ and LGE– groups. LGE+ 
patients have significantly higher basal and lower apical systolic rotation, lower twist and 
torsion when compared to LGE– patients. However, untwisting rate was similar between the 
groups. Torsion was significantly correlated with LVEF and MR-index. Patients with reversed 
apical systolic rotation had significantly greater NT-proBNP values, basal systolic rotation and 
significantly lower apical systolic rotation, torsion, and MR-index. 
Conclusions: Cardiac fibrosis index is closely related with myocardial torsion and LV systo-
lic function and may be used for the evaluation of cardiac condition. Reversed apical systolic 
rotation indicated more extensive cardiac fibrosis as it may reflect severe LV dyssynchrony and 
poor LV performance. (Cardiol J 2013; 20, 3: 276–286)
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Introduction
Heart failure remains one of the major public 
health problems in developed countries [1, 2]. Du-
ring the development of congestive heart failure in 
patients with dilated cardiomyopathy (DC), the left 
ventricle (LV) undergoes complex changes in geo-
metry, accompanied by alteration of the LV chamber 
and myocardial systolic and/or diastolic function. 
LV ejection fraction (EF) is the most commonly 
used parameter for the severity of LV systolic dys-
function in patients with congestive heart failure 
and has been used as a prognostic marker [3, 4]. 
LV rotation, twist, and torsion are also important 
aspects of the cardiac performance. Rotation of the 
LV apex relative to the base is related to the ven-
tricular efficiency. Potential energy stored by LV 
twist during the systolic phase is rapidly released 
during LV untwisting and constitutes an important 
determinant of diastolic suction and function [5]. 
Two-dimensional speckle tracking imaging (2D-
-STI) is a novel ultrasound technique for quan-
tification of LV regional deformation, myocardial 
rotation, torsion, twist and untwisting [6, 7]. This 
technique has been validated by tagged magnetic 
resonance imaging, which is currently considered 
gold standard for the assessment of myocardial ro-
tational parameters [8, 9]. Myocardial fibrosis could 
be identified as the late gadolinium enhancement 
(LGE) areas in cardiac magnetic resonance (CMR) 
studies [10, 11]. Recent studies reported that LGE 
was associated with adverse prognosis in patients 
with non-ischemic dilated cardiomyopathy (NDC) 
[11, 12]. However, there is limited data about the 
association between myocardial fibrosis and LV 
rotational parameters in NDC patients, which is 
the main purpose of this investigation.
Methods
Study population
Twenty-two patients (17 men and 5 women; 
average age 47 ± 12 years, range 27–74) with NDC 
and sinus rhythm were enrolled from the outpatient 
clinic of Koşuyolu Heart and Research Hospital, 
between September 2008 and June 2009. Patients 
with organic valvular heart disease, history of co-
ronary artery disease (acute coronary syndrome, 
revascularization history, > 50% luminal narrowing 
in any of the coronary arteries), atrial fibrillation, 
permanent pacemakers, chronic kidney disease 
(> stage 3 kidney disease), LVEF > 40%, and pa-
tients with inadequate quality for speckle-tracking 
analysis were not included. Functional capacities 
were assessed by New York Heart Association 
(NYHA) classification, and physical examination 
findings with 12-lead electrocardiograms (ECG) 
were recorded. Blood samples for N-terminal pro-
-B-type natriuretic peptide (NT-proBNP) levels 
were obtained following a resting period after 
echocardiographic examinations. All patients unde-
rwent a routine coronary angiography and cardiac 
catheterization before enrolment to the study. 
Written informed consent was obtained from 
all participants and the study was approved by the 
local ethics committee.
Electrocardiographic examination
Standard 12-lead ECG was acquired at a pa-
per speed of 25 mm/s and a scale of 10 mm/mV. 
Measurement of QRS duration (QRSd) and PR 
interval (PRd) (recorded from the surface leads de-
monstrating the greatest values) were performed 
by an experienced observer who was blind to the 
echocardiographic characteristics of the patients. 
Echocardiographic examinations
Standard measurements. All echocardio-
graphic measurements were performed using 
Vivid 7 (GE-Vingmed Ultrasound AS, Horten, 
Norway) with an M3S transducer. LV dimen-
sions were measured by 2-dimensional M-mode 
echocardiography according to the guidelines of 
the American Society of Echocardiography [13]. 
LV volumes and EFs were calculated using the 
modified biplane Simpson’s method (tracing LV 
end-diastolic and end-systolic cavities in apical 
4- and 2-chamber views). Diastolic mitral inflow 
velocities were recorded by pulsed wave Doppler 
as previously described [14]. In apical 4-chamber 
view, sample volume was placed at the tips of the 
mitral leaflets and the following variables were 
measured: maximal flow velocity in early (E wave) 
and late diastole (A wave), E wave deceleration 
time (EDT). The quantification of functional mitral 
regurgitation (MR) was performed using the pro-
ximal isovelocity surface area method [15]. Delta 
pressure/delta time (dp/dt) was calculated by the 
following formula; dp/dt [mm Hg/s] = 32/time [s] 
from the velocity of 1 to 3 m/s achieved in the MR 
Doppler curve [16]. Tissue Doppler imaging (TDI) 
was performed in the apical views (4- and 3-cham-
ber) in order to assess longitudinal velocities of the 
LV [17, 18]. Systolic velocity (Sm), early diastolic 
velocity (e’), and late diastolic velocity (a’) were 
derived from the TDI study of the septal mitral 
annulus. The early diastolic mitral inflow velocity 
(E) and e’ velocity ratio (E/e’ ratio) were obtained. 
Sample volume was placed on the lateral tricuspid 
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annulus area and right ventricular systolic velocity 
(RVs) was measured to assess right ventricular 
systolic function. 
Speckle tracking imaging. Two-dimensio-
nal, greyscale images (frame rate, 44–82 frames/s) 
were acquired and recorded for offline analysis at 
a workstation (EchoPAC, GE, Horten, Norway). 
Apical 4- and 2-chamber views were used for 
longitudinal strain and strain rate analysis while 
parasternal short-axis (SAX) views at three levels 
(the base, the level of papillary muscles and the 
apex) were used for circumferential and radial 
strain, strain rate, twist and torsion analysis. End-
-systolic regions of interest were traced on the 
endocardial cavity (minimum cavity area) using 
a point-and-click approach with special care taken 
to adjust tracking of all endocardial segments. 
A second larger concentric circle was then automa-
tically generated and manually adjusted near the 
epicardium. Speckle tracking automatically ana-
lyzed frame-by-frame movement of the speckles, 
over the cardiac cycle. Each image was divided 
into six standard segments, corresponding strain 
curves were obtained. The mean strain values were 
calculated for each SAX view, apical 4-chamber 
view and apical 2-chamber view, as the sum of 
end-systolic strain values in 6 segments, divided 
by 6. Global circumferential strain (GCS), global 
longitudinal strain (GLS), and global radial strain 
(GRS) were derived, using following formulas: 
GCS = (mean basal circumferential strain + mean 
midcircumferential strain + mean apical circumfer-
ential strain)/3, GLS = (mean longitudinal strain in 
the apical 4-chamber view + mean longitudinal strain 
in the apical 2-chamber view)/2, and GRS = (mean 
basal radial strain + mean midradial strain + mean 
apical radial strain)/3.
Two-dimensional speckle tracking analysis of 
parasternal SAX views at the base and at the apex 
revealed LV ‘rotation’ and ‘rotation rate’ curves as 
the angular displacement and the velocity of displa-
cement of the LV around its central axis. Negative 
values indicated clockwise while positive values 
indicated counterclockwise rotation. LV ‘twist’ and 
‘twist rate’ were defined as the net difference of LV 
peak systolic ‘rotation’ and ‘rotation rate’ between 
basal (clockwise) and apical (counterclockwise) 
short axis planes. Values were expressed in ‘°’ 
and ‘°/s’, respectively. ‘Untwist’ was expressed as 
a diastolic angular motion of the LV, opposite to 
twist. ‘Untwisting rate’ [°/s] was defined as the 
peak twist rate during early diastole (Fig. 1). LV 
Figure 1. Left ventricular ‘twist’ and ‘twist rate’ were defined as the net difference of left ventricular (LV) peak systolic 
‘rotation’ and ‘rotation rate’ between basal (clockwise) and apical (counterclockwise) short axis planes. Values were 
expressed in ‘°’ and ‘°/s’, respectively. Negative values indicated clockwise while positive values indicated counterc-
lockwise rotation. ‘Untwist’ was expressed as a diastolic angular motion of the LV, opposite to twist. ‘Untwisting rate’ 
[°/s] was defined as the peak twist rate during early diastole. 
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torsion was calculated as the net LV twist normali-
zed with respect to ventricular diastolic longitudi-
nal length between the LV apex and the mitral plane 
(LV torsion [°/cm] = [apical LV rotation – basal LV 
rotation]/LV diastolic longitudinal length) [19]. 
On the other hand, particular attention was paid 
to the direction of systolic apical rotation: normal 
(counterclockwise) or reversed (clockwise), which 
was documented for each patient.
Blood sampling for NT-proBNP. The blood 
samples for assessing plasma NT-proBNP levels 
were obtained by venipuncture and collected into 
ethylenediamine-tetraacetic acid tubes following 
the echocardiographic examinations. Each collec-
ted sample was centrifuged for 5 min at 2000 g and 
4°C within 30 min. The plasma was then separated 
off, frozen, and kept at –80°C until the assessment 
time. NT-proBNP was measured with a proBNP 
assay on an Elecsys 2010 analyzer (Roche Diagno-
stics, GmbH, Mannheim, Germany). According to 
data provided by the manufacturer, the detection 
limit for this peptide is 5 pg/mL.
Cardiac magnetic resonance imaging. 
CMR studies were obtained with 1.5-Tesla who-
le body scanner system (Magnetom, Avanto; 
Siemens, Medical Solutions, Erlangen, Germa-
ny) operating at a maximum gradient strength of 
45 mT × m–1 and slew rate of 200 T/m/s, using six 
anterior channels and six posterior channels for 
data acquisition. An integrated parallel acquisition 
technique (iPAT) with an acceleration factor of 
2 was used. Multislice short-axis cine imaging used 
ECG-triggered, steady-state free precession (slice 
thickness, 8 mm; interslice gap 20%) acquired 
from the atrioventricular ring to the apex. The 
CMR protocol included a functional study of the 
LV using an ECG-triggered breath-hold segmen-
ted steady-state free precession (SSFP; true fast 
imaging with steady-state free precession; FISP) 
cine sequence (temporal resolution, 44.25 ms; 
echo time (TE) 1.25 ms flip angle, 52°) with a slice 
thickness of 8 mm. The breath hold acquisition 
time was 6 to 9 s. Depending on the field of view, 
the typical in-plane resolution was 1.9 × 1.9 mm2 
for all sequences. The total imaging time, inclu-
ding patient positioning, was 45-60 min. Dynamic 
studies were performed from the short axis plane 
at the basal, mid, and apical segments by using 
0.1 mmoL/kg intravenous gadolinium contrast 
agent (Dotarem, Guerbet, France) given with a po-
wer injector (Medrad Stellant, PA, United States). 
Late enhancement scans were collected in three 
long-axis and all short-axis orientations by using 
a breath-hold ECG-triggered 2D inversion reco-
very turbo FLASH sequence (TR/TE, 8/4 ms; flip 
angle, 25°). Images were acquired subsequently 
up to 15 min after injection. CMR images were 
re-analyzed and documented by using 17-segment 
cardiac model that was recommended by the Ame-
rican Heart Association to improve standardization 
of the results [20]. LV was evaluated from the short 
axis images from basal, mid and apical segments. 
Basal and mid cavity were divided into 6 equal seg-
ments, and named as “anterior, anteroseptal, infe-
roseptal, inferior, posterolateral and anterolateral”. 
Apical segment was divided into four sub-segments 
and named as “anterior, inferoseptal, inferior, 
and anterolateral”. The apical cap was termed as 
“apex” and constituted the 17th segment. The con-
trast-enhanced images were analyzed visually by 
2 experienced observers who were blinded to other 
CMR, echocardiographic, and clinical data. LGE 
was rated by visual assessment and each segment 
was graded on a 2-point scale (segmental fibrosis 
score): 0 = absence of LGE, 1 = presence of LGE; 
with the method used by Kaandrop and coworkers 
owing to frequency of linear and patchy enhance-
ment in patients with NDC [21]. Cardiac fibrosis 
index (MRI index) was calculated by, 17– (sum of 
fibrotic segments)/17 formula [22]. The patients 
were sub-grouped into two, based on the absence 
(LGE–) and presence (LGE+) of fibrosis in any of 
the left ventricular segments. 
Statistical analysis
Statistical analysis was performed using 
a statistical software program (SPSS for Windows, 
version 15.0; SPSS Inc., Chicago, Illinois, USA). 
Data are presented as mean ± SD, controlled for 
normal distribution by Kolmogorov-Smirnov test 
and compared using unpaired Student’s t-test 
when normally distributed. Nonparametric tests 
were also applied in abnormal distribution (Mann-
-Whitney U test). Categorical data between two 
or more groups were compared by the Pearson 
c2 test. The correlation of continuous variables was 
analyzed by Pearson and categorical variables by 
Spearman correlation analysis. Linear regression 
analysis was used to identify the independent 
predictors of cardiac fibrosis in patient with NDC. 
A probability value of p < 0.05 was considered as 
significant.
Results
Study population included 5 (23%) women 
and 17 (77%) men. The age range was 27–74 ye-
ars (mean age: 47). Seven (32%) patients were in 
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NYHA class III or IV. Plasma NT-pro BNP levels 
ranged between 101 pg/mL and 2685 pg/mL, and 
the median value was 726 pg/mL. The mean LVEF 
of the study patients was 31 ± 6.8%. The mean fun-
ctional MR volume was 18 ± 9 mL. Patients were 
divided into two groups according to the presence 
of LGE in CMR. Eleven (50%) patients had LGE 
in CMR (Fig. 2). The most frequently involved 
cardiac segments were mid-inferior, mid-lateral, 
basal-lateral and basal inferior segments (Table 1). 
Multiple cardiac segments were involved in most of 
the patients (n = 5; 45.4%). Linear subendocardial 
involvement was the most frequent type (42.7%), 
followed by patchy foci transmural (31.8%), mid-
-wall stria (19.6%) and linear subepicardial (5.9%) 
involvement consecutively. 
LGE– and LGE+ groups both included 
11 patients (8 men/3 women; mean age: 51 ± 12 years 
and 9 men/2 women; mean age: 43 ± 10 years, 
respectively). LGE– and LGE+ patients were 
similar in terms of clinical, ECG and standard 
echocardiographic measurements (Tables 2, 3). 
Table 1. Frequency of fibrosis amongst the left ventricular segments.
Inferoseptum Anterolateral Anterior Inferior Antero-
septum
Posterolateral
Basal 0 (0%) 5 (45.4%) 2 (18.1%) 4 (36.3%) 2 (18.1%) 0 (0%)
Midwall 0 (0%) 5 (45.4%) 1 (9%) 6 (54.5%) 0 (0%) 1 (9%)
Apical 0 (0%) 2 (18.1%) 0 (0%) 3 (27.2%)
Table 2. The clinical, ECG and biochemical properties of LGE– and LGE+ groups.
LGE– group (n = 11) LGE+ group (n = 11) P
Age [years] 51.4 ± 12.3 43.2 ± 10.9 0.11
Female gender [%] 3 (27%) 2 (18%) 0.61
SBP/DBP [mm Hg] 110 ± 11/67 ± 8 110 ± 15/77 ± 6 0.35
NYHA class I–II/III–IV 9/2 6/5 0.18
NT-proBNP [pg/mL] 1490 ± 926 1100 ± 1043 0.49
PR duration [ms] 205.1 ± 34.0 203.0 ± 30.0 0.26
QRS duration [ms] 123.2 ± 28.6 139.4 ± 38.1 0.33
LBBB 3(27%) 2(18%) 0.15
LGE — late gadolinium enhancement; SBP/DBP — systolic/diastolic blood  pressure; NYHA — New York Heart Association; NT-proBNP — 
N-terminal pro-B-type natriuretic peptide; LBBB — left bundle branch block
Figure 2. Apical (A) and extensive (B) subendocardial late gadolinium enhancement demonstrating cardiac fibrosis.
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Myocardial deformation and rotation parameters 
calculated by speckle tracking analysis are shown 
in Table 4. GLS, GCS, GRS values were similar 
between the two groups, whereas LV rotation para-
meters were significantly different. LGE+ patients 
had significantly higher basal systolic rotation and 
significantly lower apical systolic rotation, twist 
and torsion when compared to the LGE– patients. 
However, untwisting rate was similar between the 
two groups. Torsion was significantly correlated 
with LVEF and MR-index (cardiac fibrosis index) 
(r = 0.64, p = 0.04; r = 0.80, p = 0.005, respectively) 
(Figs. 3, 4). Linear regression analysis revealed 
that only MR-index (OR 1.53, 95% CI 2.9–3.06, p = 
= 0.02) was independent correlated factor of torsion. 
Although 17 NDC patients had basal-clockwise 
and apical-counterclockwise systolic rotations 
(normally directed apical and basal rotation), 
interestingly, 5 LGE+ patients had reversed (clo-
ckwise) apical systolic rotation (Fig. 5), with signi-
ficant difference in comparison to LGE– patients. 
However, one LGE– patient had also reversed 
(counterclockwise) basal systolic rotation but it 
was not statistically significant (Table 4). None of 
the patients exhibited reversed basal and reversed 
apical systolic rotation together. Accordingly, to 
further analyze the effect of apical motion direction, 
patients were divided into two subgroups with 
respect to the presence of reversed apical systolic 
rotation. Compared to the patients with normally 
Table 4. The tissue Doppler and torsion properties of the patient groups.
LGE– group (n = 11) LGE+ group (n = 11) P
GLS [%] –8.37 ± 4.19 –8.59 ± 3.25 0.89
GCS [%] –6.84 ± 4.25 –8.44 ± 3.77 0.37
GRS [%] 19.6 ± 12.3 16.1 ± 7.42 0.43
Rot-basal [°] –2.67 ± 2.37 –5.14 ± 2.22 0.02
Rot-apical [°] 5.16 ± 2.96 –0.10 ± 4.37 0.004
Twist [°] 7.83 ± 3.03 5.04 ± 3.23 0.05
Torsion [°/cm] 1.03 ± 0.40 0.62 ± 0.44 0.03
Untwisting rate [°/s] –57.1 ± 26.8 –45.0 ± 25.0 0.28
Reversed apical rotation [%] 0 (0%) 5 (45%) 0.01
Reversed basal rotation [%] 1 (0.9%) 0 (0%) 0.31
LGE — late gadolinium enhancement; GLS — global longitudinal strain; GCS — global circumferantial strain; GRS — global radial strain; 
Rot-basal — basal left ventricular rotation; Rot-apical — apical left ventricular rotation
Table 3. The echocardiographic properties of LGE– and LGE+ groups.
LGE– group (n = 11) LGE+ group (n = 11) P
LVESD [cm] 5.41 ± 0.89 5.79 ± 1.12 0.38
LVEDD [cm] 6.37 ± 0.91 6.78 ± 1.23 0.39
LA [cm] 4.29 ± 0.74 4.40 ± 0.75 0.72
LV dp/dt [mm Hg/s] 638 ± 83.7 609.5 ± 124.9 0.08
LVEF [%] 31.5 ± 7.1 30.2 ± 6.7 0.67
E [m/s] 0.78 ± 0.35 0.81 ± 0.24 0.83
A [m/s] 0.62 ± 0.22 0.64 ± 0.24 0.83
E/A ratio 1.53 ± 1.05 1.47 ± 0.77 0.87
EDT [ms] 203.7 ± 53.9 187.9 ± 64.2 0.53
Sm [cm/s] 3.35 ± 1.09 3.62 ± 0.87 0.53
e’ [cm/s] 3.39 ± 1.48 4.03 ± 1.33 0.31
RVs [cm/s] 9.09 ± 3.07 9.5 ± 2.44 0.73
MR vol. [mL] 16.9 ± 8.8 19.0 ± 10.3 0.63
E/e’ ratio 30.5 ± 28.1 22.3 ± 10.8 0.40
LGE — late gadolinium enhancement; A — mitral inflow A wave velocity; E — mitral inflow E wave velocity; LVEF — left ventricular eje-
ction fraction; EDT — mitral inflow E wave deceleration time; E/A — mitral inflow e wave/a wave ratio; LA — left atrium diameter; LV dP/
dt — left ventricular: delta pressure/delta time; LVEDD — left ventricular end diastolic diameter; LVESD — left ventricular end systolic dia-
meter; RVs — tricuspid annulus peak systolic velocity by TDI; Sm — basal septum peak systolic velocity by TDI; e’ — basal septum early 
diastolic velocity by TDI; MR vol. — mitral regurgitation volume
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directed apical systolic rotation, those with re-
versed apical systolic rotation had similar NYHA 
functional class, conventional echocardiographic 
parameters, myocardial deformation parameters 
(GLS,GCS,GRS) and untwisting rate; but they had 
significantly greater NT-proBNP values (1547 ± 
± 945 pg/mL vs. 389 ± 303 pg/mL, p = 0.007), 
basal systolic rotation (–6.78 ± 1.21o vs. –3.06 ± 
± 2.2o, p < 0.001), and significantly lower apical 
systolic rotation (–3.71 ± 3.64o vs. 4.36 ± 2.81o, 
p < 0.001), twist (3.07 ± 3.44o vs. 7.43 ± 2.72o, 
p = 0.04), torsion (0.35 ± 0.51o/cm vs. 0.95 ± 0.38o/cm, 
p = 0.05) and MR-index (0.66 ± 0.20 vs. 0.95 ± 
± 0.06, p = 0.03) (Tables 5–7). Forty percent of 
patients (2 out of 5) with reversed apical systolic 
rotation and only 11.7% of patients (2 out of 17) 
with normally directed apical systolic rotation de-
monstrated LGE in at least one apical myocardial 
segment (p = 0.03) (Table 7). Amongst the apical 
myocardial segments, inferior-apical and antero-
lateral-apical segments were the most frequently 
affected ones.
Discussion
Main findings of the study
In this study we could demonstrate that the 
presence of cardiac fibrosis in NDC patients is 
Figure 5. In patients with cardiac fibrosis (in the middle), apical systolic rotation, and thus, left ventricular twist is lower, 
in comparison to the patients without cardiac fibrosis (in the left). However in patients with extensive cardiac fibrosis, 
reversed (clockwise) apical systolic rotation is observed (in the right). 
Figure 4. Correlation of torsion with cardiac fibrosis in-
dex (magnetic resonance imaging [MRI]-index).
Figure 3. Correlation of torsion with left ventricular eje-
ction fraction (LVEF).
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Table 7. The tissue Doppler and rotation parameters of the patients with normally directed apical rotation 
and reversed apical rotation. 
Normally directed  
apical rotation (n = 17)
Reversed apical  
rotation (n = 5)
P
GLS [%] –8.20 ± 3.73 –9.64 ± 3.72 0.52
GCS [%] –7.16 ± 4.15 –9.50 ± 3.09 0.25
GRS [%] 18.3 ± 11.2 16.2 ± 4.1 0.54
Rot-basal [°] –3.06 ± 2.2 –6.78 ± 1.21 < 0.001
Rot-apical [°] 4.36 ± 2.81 –3.71 ± 3.64 < 0.001
Twist [°] 7.43 ± 2.72 3.07 ± 3.44 0.04
Torsion [°/cm] 0.95 ± 0.38 0.35 ± 0.51 0.05
Untwisting rate [°/s] –49.08 ± 25.6 –57.9 ± 29.3 0.56
MR-index [%] 0.95 ± 0.06 0.66 ± 0.20 0.03
Apical fibrosis [%] 2 (11.7%) 2 (40%) 0.03
GLS — global longitudinal strain; GCS — global circumferantial strain; GRS — global radial strain; MR-index — fibrosis index in cardiac 
magnetic resonance; Rot-basal — basal left ventricular rotation; Rot-apical — apical left  ventricular rotation
Table 5. The clinical and biochemical properties of the patients with normally directed apical rotation 
and reversed apical rotation.
Normally directed  
apical rotation (n = 17)
Reversed apical  
rotation (n = 5)
P
Age [years] 46.6 ± 12.9 49.8 ± 9.6 0.57
Female gender [%] 3 (17.6%) 2 (40%) 0.30
SBP/DBP [mm Hg] 114 ± 9/63 ± 3 118 ± 10/72 ± 4 0.73
NYHA class I–II/III–IV 12/5 3/2 0.66
NT-proBNP [pg/mL] 389 ± 303 1547 ± 945 0.007
SBP/DBP — systolic/diastolic blood  pressure; NYHA — New York Heart Association; NT-proBNP — N-terminal pro-B-type natriuretic peptide
Table 6. The echocardiographic properties of the patients with normally directed apical rotation and 
reversed apical rotation.
Normally directed  
apical rotation (n = 17)
Reversed apical  
rotation (n = 5)
P
LVESD [cm] 5.72 ± 1.03 5.21 ± 0.89 0.32
LVEDD [cm] 6.71 ± 1.08 6.12 ± 1.07 0.31
LA [cm] 4.45 ± 0.73 3.98 ± 0.68 0.22
LV dp/dt [mm Hg/s] 675.6 ± 94.7 571.2 ± 158.1 0.28
EF [%] 30.8 ± 6.5 31.0 ± 8.7 0.97
E [m/s] 0.78 ± 0.31 0.85 ± 0.26 0.64
A [m/s] 0.60 ± 0.20 0.74 ± 0.30 0.38
E/A ratio 1.52 ± 0.92 1.42 ± 0.92 0.84
EDT [ms] 196.4 ± 47.2 193.8 ± 94.9 0.95
Sm [cm/s] 3.4 ± 0.98 3.76 ± 1.01 0.51
e’ [cm/s] 3.77 ± 1.45 3.57 ± 1.41 0.79
RVs [cm/s] 9.34 ± 2.73 9.14 ± 2.96 0.89
MR vol. [mL] 18.5 ± 10.1 15.6 ± 6.4 0.49
E/e’ ratio 26 ± 22.8 27 ± 14.4 0.90
A — mitral inflow A wave velocity; E — mitral inflow E wave velocity; LVEF — left ventricular ejection fraction; EDT — mitral inflow E wave 
deceleration time; E/A — mitral inflow e wave/a wave ratio; LA — left atrium diameter; LV dP/dt — left ventricular: delta pressure/delta 
time; LVEDD — left ventricular end diastolic diameter; LVESD — left ventricular end systolic diameter; RVs — tricuspid annulus peak  
systolic velocity by TDI; Sm — basal septum peak systolic velocity by TDI; e’ — basal septum early diastolic velocity by TDI; MR vol. — mi-
tral regurgitation volume
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related to decreased or even reversed apical 
systolic rotation, as well as decreased twist and 
torsion. Furthermore, reversed apical systolic 
rotation with consequent loss of torsion reflected 
a more advanced disease stage with more severe 
cardiac fibrosis (significantly lower MR-index), 
more severe systolic dysfunction and markedly 
increased NT-proBNP in comparison to normally 
directed apical rotation. Cardiac fibrosis was most 
frequently detected in mid-inferior, mid-lateral, 
basal-lateral and basal-inferior segments in our 
study population.
Left ventricular function  
and rotational dynamics
The twisting motion of the LV around its 
long axis results from the contraction of the ob-
liquely oriented epicardial and endocardial fibers. 
LV myofibers geometry changes smoothly from 
a slightly oblique orientation in the subendocardium 
to a circumferential orientation in the midwall and 
again to an oblique orientation in the subepicardium 
[23, 24]. Because of this typical orientation, when 
viewed from the apex, the LV performs a clockwise 
rotation at the base and counterclockwise rota-
tion at the apex, resulting in LV twist. LV twist is 
a critically important mechanism for the efficiency of 
LV function. LV apical rotation represents the main 
determinant of global LV systolic twist and torsion, 
resulting in storage of potential energy during sy-
stole, while rapid apical back rotation with sudden 
untwisting during isovolumic relaxation plays an 
important role in the suction of blood into the LV, 
generating intraventricular pressure gradients 
for LV diastolic filling [25, 26]. In our study, the 
amplitude of LV systolic rotation at basal level was 
increased while apical systolic rotation, twist and 
torsion were reduced in NDC patients with cardiac 
fibrosis compared with LGE– patients. There was 
also significant correlation between LV torsion and 
degree of systolic dysfunction (LVEF). Moreover, 
we detected reversed systolic apical rotation 
reflecting more severely impaired LV rotational 
dynamics and LV systolic performance in patients 
with cardiac fibrosis when compared to those with 
normally directed apical rotation. These changes 
in the pattern of apical rotation could be explained 
by increased LV sphericity leading to widening of 
the apex. This results in the loss of the oblique 
architecture of the ascending and descending api-
cal loop fibers which become more transverse and 
more closely resemble the horizontal fiber orien-
tation of the basal loop. In the end, progressive LV 
dilation and increased sphericity lead to changes 
in myofibre orientation and in torsional dynamics, 
triggering further deterioration of systolic and 
diastolic function.
Myocardial fibrosis and rotational dynamics
Patients with heart failure often show vary-
ing patterns of scarring and myocardial fibrosis. 
These regions of myocardial fibrosis have been 
visualized by CMR, appearing as areas of LGE [11]. 
Cardiovascular magnetic resonance is a rapidly 
evolving technology that offers a comprehensive 
assessment of heart failure patients and is now 
the gold standard imaging modality to assess 
myocardial anatomy and viability. Besides, LGE 
by CMR (LGE-CMR) strongly predicts cardiac 
adverse outcomes [12]. It can be classified as 
‘ischemic type’ and ‘non-ischemic type’. Ischemic 
type is either subendocardial or transmural and is 
located in a region which consists with the perfu-
sion territory of an epicardial coronary artery. The 
second type (non-ischemic) is patchy or linear stria 
of enhancement limited to the mid-myocardium of 
the ventricular wall [27]. Linear midwall hyperen-
hancement is usually found in the interventricular 
septum and is observed more frequently in patients 
with possible prior history of myocarditis. This 
confirms that the mechanisms of cardiac fibrosis 
formation are completely different in ischemic and 
nonischemic cardiomyopathies. 
The mechanisms for cardiac fibrosis are thou-
ght to be the result of a combination of factors inclu-
ding genetic predisposition, exposure to toxins and 
pathogens, microvascular ischemia, and abnormal 
responses of immune and metabolic pathways like 
renin-angiotensin -aldosteron system [28, 29]. 
Case reports exhibit containing myocardial midwall 
fibrosis in familial conditions such as muscular 
dystrophy [30]. Exposure to pathogens such as 
viruses triggers fibrosis. Early CMR imaging of 
patients with acute myocarditis shows characteri-
stic epicardial or midwall late enhancement in the 
acute phase [31], which may persist and subsequ-
ently develop into dilated cardiomyopathy. Histo-
pathological studies, in this early phase, confirm 
fibrosis and inflammatory exudates, while patients 
with end stage DCM show interstitial fibrosis in 
the absence of any inflammation [28]. Myocardial 
fibrosis is also associated with adverse ventricular 
remodelling leading to the development of the he-
art failure and dilated cardiomyopathy in animal and 
human studies [28, 29]. During the development of 
LV adverse remodeling, the size and shape of the 
LV change in patients with DCM and the enlarged 
ventricle exhibits a spherical configuration. Thus, 
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marked changes in LV rotational dynamics would 
be expected in this setting. In our NDC popula-
tion, we demonstrated that myocardial torsion 
was correlated with cardiac fibrosis index, defined 
by LGE-CMR, and with LVEF. Furthermore, we 
found that reversed apical rotation group exhibited 
significantly higher frequency of apical segment 
fibrosis in comparison to the normally directed 
apical rotation group. Accordingly, we conclude 
that cardiac fibrosis may be the main reason for 
disturbed apical rotation, twist and torsion in NDC 
patients. The presence of more extensive cardiac 
fibrosis (or MR-index) in patients with reversed 
apical rotation and with complete loss of torsion, 
seems like supporting this result. 
Clinical implications
The findings of our study highlight the impact 
of cardiac fibrosis on apical and basal rotation, twist 
and torsion dynamics in failing left ventricles. This 
may underscore the potential clinical benefits of 
cardiac fibrosis index, defined by LGE-CMR, for 
certain therapeutic procedures such as cardiac re-
synchronization therapy (CRT). Thus, in the future, 
cardiac fibrosis index may be a useful parameter 
to indicate LV dyssynchrony and to select CRT 
candidates, which needs further investigations. 
As we found reversed apical rotation in some 
of our NDC patients, revealing more severe LV 
disease with extensive cardiac fibrosis, this ro-
tational parameter could be useful marker to be 
assessed before and after CRT. Whether reversed 
apical rotation can identify responders to CRT 
remains to be tested.
Limitations of the study
A technical limitation was that speckle tra-
cking echocardiography is highly dependent on 
frame rates, as well as image quality. Especially 
apical rotation analysis requires good apical image 
quality. Therefore, we tried to keep frame rates 
optimal during image acquisitions and a small 
number of subjects with insufficient image quality 
were not included at the beginning. Measuring 
apical rotation from certain anatomical point also 
seems controversial. In this study, measurements 
were done at the most distal level that did not show 
luminal closure during systole [32].
Another limitation of our study was the re-
latively small extent of patient population which 
could have compromised our ability to detect the 
relation between cardiac fibrosis and rotational 
dynamics. Although our results clearly demon-
strated this relation, using larger sample size, we 
could have obtained more significant associations, 
more explanatory data underlying mechanisms of 
reversed apical rotation and its potential role in 
certain cardiac therapeutic modalities. However, 
the reason was the selection of highly specific 
patient group, with good image quality.
Conclusions
Cardiac fibrosis identified by LGE-CMR is clo-
sely related to the myocardial rotational dynamics 
in patients with NDC. Cardiac fibrosis index was 
correlated with myocardial torsion and LV systolic 
function and may be used for the evaluation of 
cardiac condition. Reversed apical systolic rotation 
indicated more severe myocardial disease with 
more extensive cardiac fibrosis and may be useful 
parameter to predict response to CRT. But since we 
didn’t have significant number of patient implanted 
CRT, we could not be able to assess this relation 
and further studies will be required. 
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